Lexicon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. META
5. IBM
6. PRIM
7. SPY
8. ACN
9. NVDA
10. BLZE

Go back to Lexicon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical Update

Lexicon Pharma (LXRX) Tops Q3 EPS by 2c

November 3, 2021 5:39 PM EDT

Lexicon Pharma (NASDAQ: LXRX) reported Q3 EPS of ($0.16), $0.02 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.

... More